Compare Revvity Inc (RVTY) vs Snap Inc (SNAP) Price & Performance

RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.

The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.

Snap Inc. (SNAP) trades at $4.56, up 0.77% on the day, with a bearish technical signal and mixed fundamentals. Revenue grew to $5.93B in 2025, but net losses persist at -$460M. The stock shows improving cash flow from operations and has beaten EPS estimates in recent quarters. Analyst consensus is a 'Hold' with a $5.83 price target, suggesting modest upside from current levels.

The outlook remains cautious due to ongoing losses and competitive pressures, though cost-cutting and AR initiatives offer potential. Key risks include high debt, regulatory scrutiny, and uncertain demand for new products like SPECS glasses. Upside depends on sustained user engagement and profitability improvements.